Table 1. Prevalence and incidence of NMOSD in Korea in 2016 and 2017.
Age, yra | Prevalence (per 100,000 population) | Incidence (per 100,000 population-year) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2016 | 2017 | 2016 | 2017 | |||||||||
Subtotal | Male | Female | Subtotal | Male | Female | Subtotal | Male | Female | Subtotal | Male | Female | |
< 15 | 0.44 | 0.17 | 0.73 | 0.48 | 0.15 | 0.84 | 0.10 | 0.06 | 0.15 | 0.05 | 0 | 0.09 |
15–29 | 3.07 | 1.14 | 5.23 | 3.12 | 1.09 | 5.39 | 0.51 | 0.26 | 0.79 | 0.27 | 0.14 | 0.40 |
30–44 | 4.89 | 2.11 | 7.79 | 5.41 | 2.32 | 8.63 | 0.77 | 0.26 | 1.30 | 0.62 | 0.28 | 0.96 |
45–59 | 4.75 | 1.55 | 7.97 | 5.04 | 1.65 | 8.48 | 1.08 | 0.46 | 1.70 | 0.67 | 0.30 | 1.04 |
≥ 60 | 2.01 | 1.12 | 2.69 | 2.01 | 1.12 | 2.67 | 0.48 | 0.27 | 0.64 | 0.27 | 0.17 | 0.34 |
Overall | 3.36 | 1.33 | 5.38 | 3.56 | 1.39 | 5.71 | 0.65 | 0.28 | 1.01 | 0.41 | 0.20 | 0.62 |
NMOSD = neuromyelitis optica spectrum disorder.
aAge means the age at which the diagnostic code for NMOSD was entered.